About this trial
The planned multicenter randomized study is aimed to assess the efficacy and safety of endoscopic pancreatic duct stenting in adult patients with acute pancreatitis. It is planned to include patients with early-stage nonbiliary pancreatitis in the study.
Eligibility criteria
Qualifiers
Diagnosis of acute pancreatitis confirmed on the basis of at least 2 of the 3 diagnostic criteria according to the revised Atlanta classification
Presence of organ failure signs (moderate and severe pancreatitis)
Informed consent of the patient
Disqualifiers
Presence of other indications for endoscopic intervention on the major duodenal papilla (biliary pancreatitis with cholangitis, calculus of the major duodenal papilla, stenosis of the major duodenal papilla, etc.)
Previous surgical interventions on the major duodenal papilla
Diverticula of the major duodenal papilla
Pregnancy
Trial design
Treatments tested in this trial
- Endoscopic pancreatic duct stent placement
- Conventional treatment of acute pancreatitis in early phase